Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
GnRH stimulant
DRUG CLASS:
GnRH stimulant
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
leuprorelin depot (1)
goserelin acetate sustained-release microspheres for injection (0)
Goserelin (0)
leuprorelin implant (0)
CKD-841 (0)
leuprorelin intranasal (0)
leuprorelin depot (1)
goserelin acetate sustained-release microspheres for injection (0)
Goserelin (0)
leuprorelin implant (0)
CKD-841 (0)
leuprorelin intranasal (0)
›
Associations
(8)
News
Trials
VERI cancer hierarchy
Reset Filters
BRCA1 mutation + BRCA2 mutation
Prostate Cancer
BRCA1 mutation + BRCA2 mutation
Prostate Cancer
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
CDK12 mutation
Prostate Cancer
CDK12 mutation
Prostate Cancer
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
BRCA2 mutation
Prostate Cancer
BRCA2 mutation
Prostate Cancer
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
ATM mutation
Prostate Cancer
ATM mutation
Prostate Cancer
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
BRCA2 mutation + CDK12 mutation
Prostate Cancer
BRCA2 mutation + CDK12 mutation
Prostate Cancer
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
BRCA2 mutation + CHEK2 mutation
Prostate Cancer
BRCA2 mutation + CHEK2 mutation
Prostate Cancer
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
ATM mutation + CDK12 mutation
Prostate Cancer
ATM mutation + CDK12 mutation
Prostate Cancer
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
BRCA2 A902fs*2
Prostate Cancer
BRCA2 A902fs*2
Prostate Cancer
abiraterone acetate + bicalutamide implant + leuprorelin depot
Resistant: C4 – Case Studies
abiraterone acetate + bicalutamide implant + leuprorelin depot
Resistant
:
C4
abiraterone acetate + bicalutamide implant + leuprorelin depot
Resistant: C4 – Case Studies
abiraterone acetate + bicalutamide implant + leuprorelin depot
Resistant
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login